Antibacterial use in the age of SARS-CoV-2.

Angell, Kathleen E; Lawler, James V; Hewlett, Angela L; Rupp, Mark E; Bergman, Scott J; Van Schooneveld, Trevor C; Broadhurst, M Jana; Brett-Major, David M

Angell, Kathleen E; Lawler, James V; Hewlett, Angela L; Rupp, Mark E; Bergman, Scott J; Van Schooneveld, Trevor C; Broadhurst, M Jana; Brett-Major, David M.

Afiliação

Angell KE; Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA.
Lawler JV; Global Center for Health Security, University of Nebraska Medical Center, Omaha, NE, USA.
Hewlett AL; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Rupp ME; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Bergman SJ; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Van Schooneveld TC; Antimicrobial Stewardship Program, Nebraska Medicine, Omaha, NE, USA.
Broadhurst MJ; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Brett-Major DM; Global Center for Health Security, University of Nebraska Medical Center, Omaha, NE, USA.

JAC Antimicrob Resist ; 3(2): dlab073, 2021 Jun.

Article em En | MEDLINE | ID: mdl-34223134

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: JAC Antimicrob Resist Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google